mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.9 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |